Anti-CD4 monoclonal antibodies in rheumatoid arthritis

Springer Seminars in Immunopathology

Volumn 20, Issue 1-2, 1998, Pages 261-273

  Choy, Ernest H S ^a   Kingsley, Gabrielle H ^b   Panayi, Gabriel S ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; OKT 4;

ANTIGEN EXPRESSION; ARTICLE; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0031787641     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00832011     Document Type: Article

References (65)

1. Afeltra A, Galeazzi M, Ferri GM, Amoroso A, De Pita O, Porzio F, Bonomo L (1993) Expression of CD69 on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann Rheum Dis 52 : 457
2. Benjamin RJ, Waldmann H (1986) Induction of tolerance by monoclonal antibody therapy. Nature 320 : 449
3. Bennett RS, Hamburger MI (1982) A critical review of therapeutic apheresis in the treatment of severe rheumatoid arthritis. Prog Clin Biol Res 106 : 33-48
4. Brennan FM, Feldmann M (1992) Cytokines in autoimmunity. Curr Opin Immunol 4 : 754
5. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M (1988) Interleukin 1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of III alpha. Clin Exp Immunol 73 : 449
6. Cole JA, McCarthy SA, Rees MA, Shallow SO, Singer A (1989) Cell surface comodulation of CD4 and T cell receptor by anti-CD4 monoclonal antibody. J Immunol 143 : 397
7. Choy EHS, Chikanza IC, Kingsley GH, Corrigall V, Panayi GS (1992) Treatment of rheumatoid arthritis with single dose or weekly pulses of chimacric anti-CD4 monoclonal antibody. Scand J Immunol 36 : 291
8. Choy EH, Pitzalis C, Cauli A, Bijl JA, Schantz A, Woody J, Kingsley GH, Panayi GS (1996) Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis Rheum 39 : 52
9. Choy EHS, Connolly DJA, Rapson N, Kingsley GH, Johnston JM, Panayi GS (1997) Effect of a humanised non-depleting anti-CD4 monoclonal antibody (mAb) on synovial fluid (SF) in rheumatoid arthritis (RA) [Abstract]. Arthritis Rheum 40 [Suppl] : S 52
10. Reference deleted
11. Darby CR, Bushell A, Morns PJ, Wood KJ (1994) Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation 57 : 1419
12. Dianzani U, Shaw A, al Ramadi BK, Kubo RT, Janeway CA Jr (1992) Physical association of CD4 with the T cell receptor. J Immunol 148 : 678
13. Doyle C, Strominger JL (1987) Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330 : 256
14. Duke O, Panayi GS, Janossy G, Poulter LW (1982) An immunohistological analysis of lymphocyte subpopulations and their micro-environment in the synovial membranes of patients with RA using monoclonal antibodies. Clin Exp Immunol 49 : 23-30
15. Emery P, Smith GN, Panayi GS (1986) Lymphocytaphoresis - a feasible treatment for rheumatoid arthrilis. Br J Rheumatol 25 : 40
16. Firestein GS, Zvaifler NJ (1990) How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33 : 768
17. Firestein GS, Xu WD, Townsend K, Broide D, Alvar-Garcia JM, Glasebrook A, Zvaifler NJ (1988) Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 168 : 1573
18. Gay D, Maddon P, Sekaly R, Talle MA, Godfrey M, Long E, Goldstein G, Chess L, Axel R, Kappler J (1987) Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 328 : 626
19. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 : 1205
20. lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor. Nature 348 : 419
21. Helfgott SM (1989) Total lymphoid irradiation. Rheum Dis Clin North Am 15 : 577-582
22. Herzog C, Walker C, Muller W, Rieber P, Reiter C, Riethmuller G, Wassmer P, Stockinger H, Madic O, Pichler WJ (1989) Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmunity 2 : 627
23. Horneff G, Burmester GR, Emmrich F, Kalden JR (1991) Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 34 : 129
24. Horneff G, Krause A, Emmrich F, Kalden JR, Burmester GR (1991) Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis. Eur Cytokine Netw 3 : 266
25. Houssiau F, Devogelaer JP, Van Damme J, Nagant de Deuxchaisnes C, Van Snick J (1988) Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31 : 784
26. Hutchings P, O'Reilly L, Parish NM, Waldmann H, Cooke A (1992) The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice. Eur J Immunol 22 : 1913
27. Isler P, Vey E, Zhang JH, Dayer JM (1993) Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. Eur Cytokine Netw 4 : 15
28. Jonsson B, Rehnberg C, Borgquist L, Larsson SE (1992) Locomotion status and costs in destructive rheumatoid arthritis. A comprehensive study of 82 patients from a population of 13000. Acta Orthop Scand 63 : 207
29. Kazazi F, Mathijs JM, Foley P, Cunningham AL (1989) Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J Gen Virol 70 : 2661
30. Kavanaugh AF, Schulze-Koops H, Davis LS, Lipsky PE (1997) Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule-1 monoclonal antibody. Arthritis Rheum 40 : 849
31. Kingsley GH, Choy EHS, Adjaye J, Forrest L, Panayi GS (1993) Induction of apoptosis is one mechanism of action of anti-CD4 monoclonal antibody [Abstract]. J Immunol 150 : S 5424
32. Kirkham BW, Pitzalis C, Kingsley GH, Chikanza IC, Sabharwal S, Barbatis C, Grahame R, Gibson T, Amlot PL, Panayi GS (1991) Monoclonal antibody treatment in rheumatoid arthritis: clinical and immunological effects of a CD7 monoclonal antibody. Br J Rheumatol 30 : 459
33. Lanchbury JS, Sakkas LI, Panayi GS (1992) Genetic factors in rheumatoid arthritis. In: Smolen JR, Kalden JR, Maini RN (eds) Rheumatoid arthritis: recent research advances. Springer, Berlin Heidelberg New York, pp 17-28
34. Levy R, Weisman M, Wiesenhutter C, Yocum D, Schnitzer T, Goldman A, Schiff M, Breedveld F, Solinger A, MacDonald B, Lipani J (1996) Results of a placebo-controlled, multicenter trial using a primatized, non-depleting, anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis [Abstract]. Arthritis Rheum 39 [Suppl] : S 122
35. Marks C, Marks JD (1996) Phage libraries - a new route to clinically useful antibodies. N Engl J Med 335 : 730
36. Mazerolles F, Hauss P, Barbat C, Figdor CG, Fischer A (1991) Regulation of LFA- 1-mediated T cell adhesion by CD4. Eur J Immunol 21 : 887
37. Menegazzi M, Suzuki H, Carcereri de Prati A, Tommasi M, Miwa M, Gandini G, Gerosa F (1992) Increase of poly(ADP-ribose) polymerase mRNA levels during TPA-induced differentiation of human lymphocytes. FEBS Lett 297 : 59
38. Moreland LW, Bucy RP, Tilden A, et al (1993) Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum 36 : 307
39. Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WJ (1994) Treatment of refractory rheumatoid arthritis with chimaeric anti-CD4 antibody. Long-term follow up of CD4+ T cell counts. Arthritis Rheum 37 : 834
40. Nakajima H, Hiyama Y, Takamori H, Tsukada W (1993) Cell mediated transfer of collagen-induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon-gamma and cyclophosphamide. Clin Exp Immunol 92 : 328
41. Newman I, Connolly DA, Choy EHS, Rapson N, Panayi GS (1997) Therapeutic effective humanised non-depleting anti-CD4 monoclonal antibody 4162w94 has no effect on monocytoid cell lines [Abstract]. Immunology 92 [Suppl] : 117
42. Olsen NJ, Brooks RH, Cush JJ, Lipsky PE, St.Clair EW, Matteson EL, Gold KN. Cannon GW, Jackson CG, McCune WJ, et al. A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. Arthritis Rheum 39 : 1102
43. Owens T, Fazekas de St., Groth BF, Miller JF (1987) Coaggregation of the T-cell receptor with CD4 and other T-cell surface molecules enhances T-cell activation. Proc Natl Acad Sci USA 84 : 9209
44. Panayi GS, Lanchbury JS, Kingsley GH (1992) The importance of the T cell in initialing and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35 : 729
45. Panayi GS, Choy EHS, Connolly DJA, Manna VK, Regan T, Rapson N, Kingsley GH, Johnston JM (1996) T cell hypothesis in rheumatoid arthritis (RA) tested by humanised non-depleting anti-CD4 monoclonal antibody (mAb) treatment. 1. Suppression of disease activity and acute phase response [Abstract]. Arthritis Rheum 39 [Suppl] : S 244
46. Paulus HE, Scott DL, Edmonds JP (1992) Classification of antirheumatic drugs. A new proposal. Arthritis Rheum 35 : 364
47. Pincus T, Callahan LF (1986) Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status and comorbidity. J Rheumatol 13 : 841
48. Poulter LW, Duke O, Hobbs S, Janossy G, Panayi GS (1982) Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritis synovial lining. Clin Exp Immunol 48 : 381
49. Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci USA 76 : 4061
50. Reinhold U, Abken H, Kukel S, Moll M, Muller R, Ollermann I, Kreysel HW (1993) CD7-T cells represent a subset of normal human blood lymphocytes. J Immunol 150 : 2081
51. Ruderman EM, Weinblatt ME, Thurmond LM, Pinkus GS, Gravallese EM (1995) Synovial tissue response to treatment with Campath-1H. Arthritis Rheum 38 : 254
52. Ryn SE, Kwong PD, Truneh A (1990) Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348 : 419
53. Schmidt C, Franch A, Buchner E, Lehmann M, Billingham M, Castell M, Emmrich F, Kinne RW (1995) Comparative effects of anti-CD4 monoclonal antibodies directed against different CD4-epitopes in the prevention of rat adjuvant arthritis [Abstract]. Clin Rheumatol 14 : 267
54. Scoazec JY, Feldmann G (1990) Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology 12 : 505
55. Scott DL, Symmons DP, Coulton BL, Popert AJ (1987) Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet I: 1108
56. Ueo T, Tanaka S, Tominaga Y, Ogawa H, Sakurami T (1979) The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis. Arthritis Rheum 22 : 1405
57. Van den Brock MF, Van de Langerijt LG, Van Bruggen MC, Billingham ME, Van den Berg WB (1992) Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis. Eur J Immunol 22 : 57
58. Van der Lubbe PA, Dijkmans BA, Markusse HM, Nassander U, Breedveld FC (1995) A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum 38 : 1097
59. + cells in patients with rheumatoid arthritis. J Autoimmun 10 : 87
60. Waldmann H, Cobbold SP (1991) Is tolerance therapy a plausible possibility? Br J Rheumatol 30 [Suppl 1] : 75
61. Weinblatt ME, Coblyn JS, Fraser PA, Anderson RJ, Spragg J, Trentham DE, Austen KF (1987) Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum 30 : 11
62. Wendung D, Wijdenes J, Racadot E, Morel Fourrier B (1991) Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J Rheumatol 18 : 325
63. While R, Teitschend RJ, Robbins DL (1988) Co-existant PMR and classical RA. Br J Rheumatol 28 : 418
64. Wijnands MJ, Hof MA van't, Leeuwen MA van, Rijswijk MH van, Putte LB van de, Riel PL van (1992) Long-term second-line treatment: a prospective drug survival study. Br J Rheumatol 31 : 253
65. Winter G, Harris WJ (1993) Humanized antibodies. Immunol Today 14 : 243